NewCardio (NWCI) Stock Overview

A cardiac diagnostic and services company, focuses on the research, development, and commercialization of proprietary software platform technology solutions for the non-invasive diagnosis and monitoring of cardiovascular disease (CVD), as well as the cardiac safety assessment of drugs under development. More details

NWCI fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($40)

Latest financial reports are more than a year old

Shares are highly illiquid

NWCI Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW494,271 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.

Grow your followingReal investors. The kind who actually invest, not scroll past.

Unlock free accessFree premium subscription for consistent and quality authors.

Learn more Create Narrative

494,271 investors already sharing narratives

View all narratives

NewCardio, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for NewCardio
Historical stock prices
Current Share Price	US$0.000001
52 Week High	US$0.0001
52 Week Low	US$0.000001
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	0%
3 Year Change	n/a
5 Year Change	-99.90%
Change since IPO	-99.90%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	NWCI	US Healthcare Services	US Market
7D	0%	-0.6%	-1.4%
1Y	0%	-35.2%	17.1%

Return vs Industry: NWCI exceeded the US Healthcare Services industry which returned -35.2% over the past year.

Return vs Market: NWCI underperformed the US Market which returned 17.1% over the past year.

Price Volatility

Is NWCI's price volatile compared to industry and market?
NWCI volatility
NWCI Average Weekly Movement	n/a
Healthcare Services Industry Average Movement	10.0%
Market Average Movement	7.2%
10% most volatile stocks in US Market	16.4%
10% least volatile stocks in US Market	3.2%

Stable Share Price: NWCI's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine NWCI's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2004	n/a	Jess Jones	n/a

NewCardio, Inc., a cardiac diagnostic and services company, focuses on the research, development, and commercialization of proprietary software platform technology solutions for the non-invasive diagnosis and monitoring of cardiovascular disease (CVD), as well as the cardiac safety assessment of drugs under development. The company’s technology platform provides real-time and 3-D analysis of the heart's electrical activity as detected at the body surface by standard 12-lead electrocardiogram (ECG) electrodes. Its developing products include QTinno, an automated cardiac safety solution that replaces the manual and/or semi-automated methodologies with algorithms that automatically measure, analyze, and report on the ECGs collected; and CardioBip, a mobile ECG transtelephonic system comprising a mobile ECG recording and transmitting device, and a Web enabled software which receives, processes, and analyzes the data.

NewCardio, Inc. Fundamentals Summary

How do NewCardio's earnings and revenue compare to its market cap?
NWCI fundamental statistics
Market cap	US$40.00
Earnings (TTM)	-US$8.84m
Revenue (TTM)	US$238.58k

0.0x

P/S Ratio

0.0x

P/E Ratio

Is NWCI overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NWCI income statement (TTM)
Revenue	US$238.58k
Cost of Revenue	US$167.77k
Gross Profit	US$70.81k
Other Expenses	US$8.91m
Earnings	-US$8.84m

Last Reported Earnings

Sep 30, 2011

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did NWCI perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/07/21 18:58
End of Day Share Price	2026/06/15 00:00
Earnings	2011/09/30
Annual Earnings	2010/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

NewCardio, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Raymond Myers	Benchmark Company